Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Androctonus crassicauda venom neurotoxins are a complex mixture of potent peptides derived from the Arabian fat-tailed scorpion, primarily targeting voltage-gated sodium (Nav) and potassium (Kv) channels in the nervous system (PMID: 15530640). These toxins, including alpha- and beta-scorpion toxins, interfere with the normal gating mechanisms of ion channels, leading to persistent sodium currents and neuronal hyperexcitability (PMID: 21807027). This hyperexcitability triggers a massive systemic release of catecholamines and acetylcholine, often referred to as an autonomic storm, which can result in severe cardiovascular distress, pulmonary edema, and neuromuscular dysfunction. In a pharmacological context, these neurotoxins are the primary targets for antivenom therapy, where equine-derived antibodies or F(ab')2 fragments neutralize the toxins' ability to bind to their physiological receptors. The concept of paraspecificity is central to treatment, as antivenoms produced against A. crassicauda often exhibit cross-neutralization against structurally similar toxins from other medically important scorpion species within the Buthidae family (PMID: 19154718).
Antivenoms function by providing specific antibodies or antibody fragments (e.g., F(ab')2) that bind to and sequester circulating neurotoxins, forming non-toxic complexes that prevent the toxins from interacting with voltage-gated ion channels (PMID: 19154718).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Androctonus crassicauda venom neurotoxins (Acra toxins).